Business News • PR NewsWire • Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack

Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack

Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack

NATICK, Mass. and ATLANTA, March 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of one-year subset data from the HORIZONS AMI trial assessing the impact of diabetes on clinical and angiographic outcomes in heart attack patients treated

View More : http://www.prnewswire.com/news-releases/study-shows-superior-efficacy-for-taxusr-expressr-stents-at-one-year-compared-to...

Releted News by prnewswire

Movie Theaters Asked to Offer Healthier Snacks at Concession Stands

BancorpSouth Files Annual Report on Form 10-K for 2009